23rd Jul 2019 09:33
(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it has signed a five-year agreement to manufacture and supply medications for non-profit US corporation Civica Inc.
Generic pharmaceutical firm Hikma will produce 14 injectable medications for Civica which "are used daily by hospitals in emergency care, surgery, pain management and in treating hypertension".
The products "will be publicly announced in the near future" with shipments to commence by the end of the year. The drugs will be produced using Hikma's Abbreviated New Drug Applications with Civia's labelling and National Drug Code.
Civica is a non-profit company and its goal is to stabilise the supply of generic medicines within hospitals, including through strategic stockpiling. More than 30 health systems in the US are Civica members, which equates to over 900 hospitals.
The value of the agreement has not been disclosed.
"Hikma is thrilled to be partnering with Civica to reduce drug shortages, and we share their commitment to providing hospitals and doctors with a steady and reliable supply of high-quality injectable medicines needed for successful patient care," said Daniel Motto, Hikma's executive vice president of Commercial & Business Development, US Injectables.
"This agreement recognises both our ability to deliver a large and consistent supply of quality medicines, and the significant investments we have made to expand our injectable manufacturing capacity and capabilities," Motto added.
Shares in Hikma were up 0.3% at 1,808.00 pence on Tuesday morning.
Related Shares:
Hikma Pharmaceuticals